IDEAYA Biosciences, Inc. IDYA on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001676725
0001676725
EIN:
47-4268251
47-4268251
LEI:
(CF Office: 03 Life Sciences)
Business address:
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Phone: 650-443-6209
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Phone: 650-443-6209
Mailing address:
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Category:
Large accelerated filer
Large accelerated filer
Filings:
424 EDGAR filings since August 26, 2016
424 EDGAR filings since August 26, 2016
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- February 18, 2025 - S-8: Securities to be offered to employees in employee benefit plans Open documentClick to Open document FilingOpen filingClick to Open filing
- February 18, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- February 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
Selected Filings
[+] 8-K (current reports)
- February 13, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- February 10, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- December 30, 2024 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 18, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 4, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 6, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 6, 2024 - 10-Q/A: Quarterly report for quarter ending March 31, 2024 - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- May 7, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 19, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- February 28, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 28, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- February 28, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 5, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 48 of 424 entries
Data source:
CIK0001676725.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
